Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
International Journal of Hematology
|
January 17, 2002
Hematological effects of intermittent 2-hour infusions of cladribine in multiple sclerosis patients: a comparison of 2 dosage patterns
P Grieb, J Kamienowski, M Janisz, et al.
Journal of Biomedicine & Biotechnology
|
October 24, 2012
Cytotoxicity of bacterial metabolic products, including listeriolysin O, on leukocyte targets
R Stachowiak, M Lyzniak, B K Budziszewska, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
February 28, 2002
[Adverse effects of parenteral administration of antisense oligonucleotides]
A Białek, M Kawalec, G Hoser, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
|
September 17, 2009
The experimental study of polyelectrolyte coatings suitability for encapsulation of cells
L H Granicka, M Antosiak-Iwańska, E Godlewska, et al.
Leukemia
|
April 27, 2011
Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis
M Koptyra, T Stoklosa, G Hoser, et al.
Blood
|
May 16, 1998
Role of p53 in hematopoietic recovery after cytotoxic treatment
P Wlodarski, M Wasik, M Z Ratajczak, et al.
Molecular Cell
|
October 31, 2001
BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance
A Slupianek, C Schmutte, G Tombline, et al.
Cancer Research
|
March 31, 2001
Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis
A Slupianek, M Nieborowska-Skorska, G Hoser, et al.
Cancer Research
|
August 28, 2001
Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells
M Nieborowska-Skorska, A Slupianek, L Xue, et al.
Journal of the National Cancer Institute
|
January 15, 1997
Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides
T Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
International Journal of Hematology
|
January 17, 2002
Hematological effects of intermittent 2-hour infusions of cladribine in multiple sclerosis patients: a comparison of 2 dosage patterns
P Grieb, J Kamienowski, M Janisz, et al.
Journal of Biomedicine & Biotechnology
|
October 24, 2012
Cytotoxicity of bacterial metabolic products, including listeriolysin O, on leukocyte targets
R Stachowiak, M Lyzniak, B K Budziszewska, et al.
Polskie Archiwum Medycyny Wewnetrznej
|
February 28, 2002
[Adverse effects of parenteral administration of antisense oligonucleotides]
A Białek, M Kawalec, G Hoser, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
|
September 17, 2009
The experimental study of polyelectrolyte coatings suitability for encapsulation of cells
L H Granicka, M Antosiak-Iwańska, E Godlewska, et al.
Leukemia
|
April 27, 2011
Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis
M Koptyra, T Stoklosa, G Hoser, et al.
Blood
|
May 16, 1998
Role of p53 in hematopoietic recovery after cytotoxic treatment
P Wlodarski, M Wasik, M Z Ratajczak, et al.
Molecular Cell
|
October 31, 2001
BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance
A Slupianek, C Schmutte, G Tombline, et al.
Cancer Research
|
March 31, 2001
Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis
A Slupianek, M Nieborowska-Skorska, G Hoser, et al.
Cancer Research
|
August 28, 2001
Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells
M Nieborowska-Skorska, A Slupianek, L Xue, et al.
Journal of the National Cancer Institute
|
January 15, 1997
Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides
T Skorski, M Nieborowska-Skorska, P Wlodarski, et al.
Page
of 5